Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IB Trial of Neoadjuvant Multi-Epitope HER2 Peptide Vaccine in Patients With HER2-Expressing DCIS

NCT04144023 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT04144023
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04144023 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IB Trial of Neoadjuvant Multi-Epitope HER2 Peptide Vaccine in Patients With HER2-Expressing DCIS
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Recruiting
Start date
June 27, 2019
Completion date
December 31, 2027
Enrollment
43 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast ductal carcinoma in situ